PreprintCited by 33Protein Tyrosine PhosphatasesPI3K/AKT/mTOR signaling in cancerMicrotubule and mitosis dynamics

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Cellular toxicity of iHAP1 and DT-061 does not occur through PP2A-B56 targeting

Open access

Preprint — published as 10.15252/embj.2022110611 · Paper page

Abstract

PP2A is an abundant phosphoprotein phosphatase that acts as a tumor suppressor. For this reason, compounds able to activate PP2A are attractive anticancer agents. The small molecule compounds iHAP1 and DT-061 have recently been reported by Leonard et al. (2020) and Morita et al. (2020) in Cell to selectively stabilize specific PP2A-B56 complexes which mediate cell killing. Here, we show that this is not the case and question key findings in these papers. Through genome wide CRISPR-Cas9 screens, we uncover the biological pathways targeted by these compounds. We find that iHAP1 directly blocks microtubule assembly both in vitro and in vivo and thus acts as a microtubule poison. In contrast, DT-061 disrupts both the Golgi apparatus and the endoplasmic reticulum and we directly visualize DT-061 in cytoplasmic granules that co-localize with Golgi markers. Our work demonstrates that iHAP1 and DT-061 cannot be used for dissecting PP2A-B56 biology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.07.08.451586

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 63

  1. 10.1111/febs.14617 · DOI
  2. 10.1016/j.biocel.2018.01.005 · DOI · Paper page
  3. 10.1016/j.molmed.2008.02.001 · DOI · Paper page
  4. Vainonen, J.P. , M. Momeny , and J. Westermarck , Druggable cancer phosphatases.Sci Transl Med, 2021. 13(588). · DOI
  5. 10.1016/S0955-0674(99)00074-5 · DOI
  6. 10.1016/j.molcel.2016.06.024 · DOI · Paper page
  7. 10.1083/jcb.201809138 · DOI
  8. 10.1083/jcb.201606033 · DOI · Paper page
  9. 10.1016/j.cell.2020.04.005 · DOI
  10. 10.1016/j.cell.2020.03.038 · DOI · Paper page
  11. 10.1016/j.cell.2020.03.051 · DOI
  12. 10.1172/JCI65093 · DOI · Paper page
  13. 10.1016/j.bmc.2015.07.007 · DOI
  14. 2017, Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth, J Clin Invest, 127, 2081, 10.1172/JCI89548 · DOI · Paper page
  15. 10.1074/mcp.RA118.000822 · DOI
  16. 10.1016/j.devcel.2017.01.012 · DOI
  17. 10.1038/nature05351 · DOI · Paper page
  18. 10.1016/j.molcel.2008.08.006 · DOI
  19. 10.1016/j.molcel.2009.06.031 · DOI
  20. 10.1016/j.cell.2015.11.015 · DOI · Paper page
  21. 10.1126/science.1247005 · DOI · Paper page
  22. 10.1126/science.1246981 · DOI · Paper page
  23. 10.1038/s41586-018-0291-z · DOI
  24. 2021, Genome-scale chemogenomic CRISPR screens in human cells using the TKOv3 library, STAR Protoc, 2, 100321, 10.1016/j.xpro.2021.100321 · DOI · Paper page
  25. 10.1186/s13073-019-0665-3 · DOI
  26. Zhang, G. , et al., Efficient mitotic checkpoint signaling depends on integrated activities of Bub1 and the RZZ complex. EMBO J, 2019. 38(7). · DOI
  27. 10.1038/onc.2010.354 · DOI
  28. 10.1016/j.molcel.2017.09.012 · DOI
  29. 10.1021/jm200436t · DOI
  30. 2016, TRAPP Complexes in Secretion and Autophagy, Front Cell Dev Biol, 4, 20
  31. 10.1016/S0006-291X(03)01316-0 · DOI
  32. Starheim, K.K. , et al., Depletion of the human N-terminal acetyltransferase hNaa30 disrupts Golgi integrity and ARFRP1 localization. Biosci Rep, 2017. 37(2). · DOI
  33. 10.1038/ncb1120 · DOI
  34. 10.1111/j.1600-0854.2009.00906.x · DOI
  35. 10.1038/nature13474 · DOI · Paper page
  36. 1994, Dominant inhibitory mutants of ARF1 block endoplasmic reticulum to Golgi transport and trigger disassembly of the Golgi apparatus, J Biol Chem, 269, 1437, 10.1016/S0021-9258(17)42277-0 · DOI · Paper page
  37. 10.3109/09687688.2010.533706 · DOI
  38. 2013, Interactions of phenothiazine drugs with surfactants: a detailed physicochemical overview, Adv Colloid Interface Sci, 199-200, 1, 10.1016/j.cis.2013.06.008 · DOI
  39. 1948, Methylene blue as a vital stain for the Golgi apparatus, Nature, 162, 736, 10.1038/162736a0 · DOI
  40. 10.1111/tra.12272 · DOI
  41. Tummino, T.A. , et al., Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2. bioRxiv, 2021. · DOI
  42. 10.1091/mbc.E09-04-0356 · DOI
  43. 10.1371/journal.pone.0029919 · DOI
  44. 10.1242/jcs.122481 · DOI · Paper page
  45. Nasa, I. , et al., Quantitative kinase and phosphatase profiling reveal that CDK1 phosphorylates PP2Ac to promote mitotic entry. Sci Signal, 2020. 13(648). · DOI
  46. 10.1002/pmic.201200439 · DOI · Paper page
  47. 10.1038/nmeth1019 · DOI · Paper page
  48. 10.1002/pmic.201100120 · DOI
  49. 10.1002/jcc.20084 · DOI
  50. 10.1107/S0907444910007493 · DOI · Paper page
  51. 10.1107/S0907444909052925 · DOI · Paper page
  52. 10.1534/g3.117.041277 · DOI · Paper page
  53. 10.1016/j.cell.2015.02.038 · DOI · Paper page
  54. 10.1186/s13059-014-0554-4 · DOI · Paper page
  55. 10.1186/s12859-016-1015-8 · DOI
  56. 10.1016/S1046-5928(03)00218-3 · DOI
  57. 10.1016/B978-0-12-407757-7.00014-1 · DOI
  58. 10.1038/s41422-019-0187-y · DOI
  59. 2020, Microtubule poleward flux in human cells is driven by the coordinated action of four kinesins, EMBO J, 39, e105432, 10.15252/embj.2020105432 · DOI
  60. 10.1038/nprot.2006.179 · DOI
  61. 10.1038/nmeth.2019 · DOI · Paper page
  62. 1995, Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells, Oncogene, 10, 2297
  63. 2020, Comprehensive Evaluation of a Quantitative Shotgun Lipidomics Platform for Mammalian Sample Analysis on a High-Resolution Mass Spectrometer, J Am Soc Mass Spectrom, 31, 894, 10.1021/jasms.9b00136 · DOI

Metadata

Authors
Vit, G., Duro, J., Rajendraprasad, G., Hertz, E. P. T., Kauffeldt Holland, L. K., Weisser, M. B., McEwan, B. C., Lopez-Mendez, B., Montoya, G., Mailand, N., Maeda, K., Kettenbach, A., Barisic, M., & Nilsson, J.
Affiliations
  • University of Copenhagen (DK)
  • Danish Cancer Society (DK)
  • Dartmouth College (US)
Corresponding author
Nilsson, Jakob
Venue
The EMBO Journal
Publisher
openRxiv
Published
2021-07-09
Volume
41
Issue
14
Pages
e110611-e110611
ISSN
0261-4189 (ISSN-L)
OpenAlex
W4282828326
Cited by
33
References
1
Citations by year
2026: 7 · 2025: 6 · 2024: 9 · 2023: 5 · 2022: 5 · 2021: 1
FWCI
2.11
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • The EMBO Journal (publishedVersion, other-oa)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, cc-by)
Funders
  • Kræftens Bekæmpelse (R146‐A9322, R269-A15586-B17)
  • Wellcome Trust (202811/Z/16/Z, 202811)
  • Danish Cancer Society Research Center (R146‐A9322, R269‐A15586‐B17)
  • Lundbeckfonden (NNF14CC0001, 2017-3212, R215‐2015-4081)
  • Novo Nordisk (NNF14CC0001, NNF17CC0027852)
  • Danish e-Infrastructure Cooperation
  • Novo Nordisk Fonden (NNF 14CC0001, NNF18OC0030752, NNF18OC0032996, (grant NNF14CC0001), NNF17CC0027852, NNF20OC0065098, NNF19OC0058504, NNF18CC0033876, NNF18OC0053124)
  • Danmarks Frie Forskningsfond (6108–00542B, 7016‐00055, 0134‐00199B, 8021‐00101B)
  • H. Lundbeck A/S
  • National Institutes of Health
  • National Cancer Institute (R33CA225458)
  • National Institute of General Medical Sciences (R35GM119455)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
Keywords
protein phosphatase 2A, PP2A activators, synthetic lethality, microtubule assembly inhibition, Golgi apparatus, endoplasmic reticulum, lipogenesis, anticancer agents
MeSH terms
Protein Processing, Post-Translational, Apoptosis, Protein Phosphatase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review